Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

5500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-01

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

observational, non-interventional, retrospective, single-center study focusing on patients with lymphoma / lymphoproliferative syndrome between January 1980 and September 2021

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Italian Study of Patients With Lymphoma

NCT06814925

Lymphoma

RECRUITING

Study on Plasmablastic Lymphoma Patients

NCT06781359

Plasmablastic Lymphoma

RECRUITING

Italian Multicenter Retrospective Observational Study on Transformed Lymphomas

NCT02927756

Non-Hodgkin Lymphoma Transformed Recurrent

UNKNOWN

Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context

NCT06781450

Primary Mediastinal B Cell Lymphoma

RECRUITING

An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme

NCT06734078

DLBCL - Diffuse Large B Cell Lymphoma

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

observational, non-interventional, retrospective, single-center study focusing on patients with lymphoma / lymphoproliferative syndrome between January 1980 and September 2021.

Study objectives are to enrich the data on the prognostic role of clinical and epidemiological factors associated with clinical and epidemiological data of patients;

* to identify the factors that affect the evolution of the disease, such as lifestyle and occupational factors, as well as the type of treatment;
* to provide a platform for future research projects;
* Description of the various therapies that have occurred over time, duration of treatment, causes of interruption of treatment, responses;
* Description of the adverse events / safety of the various therapies for lymphoma and lymphoproliferative syndromes;
* Patient survival. Descriptive analyses will be conducted by tabulating frequency distributions and percentages and mean and median values, standard deviations, quartiles and extreme values for continuous variables. Progression-free survival, disease-free survival and overall survival will be examined using Kaplan-Meier point estimates

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphoproliferative Syndrome, Autoimmune Lymphoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 18 years of enrollment
* Diagnosis of lymphoma or lymphoproliferative syndrome between January 1980 and September 2021
* Signature of the informed consent form where applicable